Hypoxia-inducible factor-1α (HIF-1α) and its signaling pathway are key mediators that enable cellular adaptation to hypoxic conditions, promote immunosuppression, and drive tumor progression and resistance to immunotherapy[9]. This evidence concerns the gene HIF1A and neoplasm.